Maria Lewandowska

The JAK2 V617F mutational status and allele burden may be related with the risk of venous thromboembolic events in patients with Philadelphia-negative myeloproliferative neoplasms

Martyna Borowczyk, Marzena Wojtaszewska, Krzysztof Lewandowski et al. · Thrombosis Research · 2014 · 84 citations

Medicine, Genetics, Hematology +16

The relationship between mean platelet volume and thrombosis recurrence in patients diagnosed with antiphospholipid syndrome

Joanna Rupa‐Matysek, Lidia Gil, Ewelina Wojtasińska et al. · Rheumatology International · 2014 · 32 citations · Full text

Medicine, Hematology, Immunology +17

Dasatinib treatment can overcome imatinib and nilotinib resistance in CML patient carrying F359I mutation of BCR-ABL oncogene

Marta Barańska, Krzysztof Lewandowski, Michał Gniot et al. · Journal of Applied Genetics · 2008 · 25 citations

Medicine, Genetics, Molecular Genetics +9

The prognostic significance of surface dipeptidylpeptidase IV (CD26) expression in B-cell chronic lymphocytic leukemia

Magdalena Matuszak, Krzysztof Lewandowski, Anna Czyż et al. · Leukemia Research · 2016 · 18 citations

Life Sciences, Immunology, Oncology +7

Frequency of BCR‑ABL gene mutations in Polish patients with chronic myeloid leukemia treated with imatinib. A final report of the MAPTEST study

Krzysztof Lewandowski, Krzysztof Warzocha, Andrzej Hellmann et al. · Polskie Archiwum Medycyny Wewnętrznej · 2009 · 16 citations · Full text

Life Sciences, Genetics, Hematology +10